In financial accounting, a balance sheet is a summary of the financial balances of an individual or organization, whether it be a sole proprietorship, a business partnership, a corporation, private limited company or other organization such as government or not-for-profit entity.

Aroa Biosurgery Limited Balance Sheet Statement - Assets

As of 31 Mar 2022, The total current assets of Aroa Biosurgery Limited (ASX:ARX) was around $79,879,000 which consisted of $6,165,000 of Cash, $3,981,000 of Inventory and $17,169,000 of Net receivables. Current assets represent all the assets of a company that are expected to be conveniently sold, consumed, used, or exhausted through standard business operations within one year.

All amounts in NZD

Cash
$6.17M
Current assets
$79.88M
Total assets
$112.65M

The latest balance sheet of Aroa Biosurgery Limited also showed $15,356,000 of Property Plant Equipment and $5,538,000 of Good will. Also there were $11,731,000 of Intangible assets and $149,000 of Other assets. The total assets including current and Intangibles/Deferred Long Term Asset Charges were $112,653,000.

Aroa Biosurgery Limited Balance Sheet Statement - Liabilities

ARX's latest annual results shows the balance sheet has $1,333,000 of Accounts Payable. Also there were no Short/Long term debt, no Long term debt, $100,000 of Other Current liabilities and $6,711,000 of Total Current Liabilities. Current liabilities are a company's short-term financial obligations that are due within one year or within a normal operating cycle.

Account payable
$1.33M
Current liabilities
$6.71M
Total liabilities
$12.16M

As per the 31 Mar 2022's annual report of Aroa Biosurgery Limited, the total liabilities were $12,162,000.

ARX Balance Sheet Statement - Stock Holder Equity

Stockholders' equity, also referred to as shareholders' equity, is the remaining amount of assets available to shareholders after all liabilities have been paid. It is calculated either as a firm's total assets less its total liabilities or alternatively as the sum of share capital and retained earnings less treasury shares. Stockholders' equity might include common stock, paid-in capital, retained earnings and treasury stock.

The latest Balance sheet of Aroa Biosurgery Limited showed the total stock holder equity was $100,491,000 which consisted of $145,755,000 of Common stocks, $-51,128,000 of Retained earnings and $5,864,000 of Other stock holder equity.

ARX Balance Sheet Statement History

Following table shows the history of balance sheet for Aroa Biosurgery Limited (ARX).

31 Mar 2022 31 Mar 2021 31 Mar 2020 31 Mar 2019
Cash 6.17M 15.38M 3.85M 4.46M
Net Receivables 17.17M 7.23M 7.39M 5.47M
Inventory 3.98M 3.61M 4M 2.68M
Total Current Assets 79.88M 48.75M 17.98M 13.15M
Property Plant Equipment 15.36M 12.66M 8.73M 6.09M
Good Will 5.54M 5.54M 5.54M 5.54M
Intangible Assets 11.73M 12.54M 13.52M 14.55M
Other Assets 149k 171k 193k 216k
Deferred Long Term Asset Charges - - - -
Total Assets 112.65M 79.66M 45.96M 39.54M
Accounts Payable 1.33M 740k 1.2M 454k
Short/Long Term Debt - 9.95M 22.52M 5.07M
Other Current Liabilities 100k 27k 7.24M 363k
Long Term Debt - - 1.12M 19.23M
Other Liabilities 164k 161k 158k 154k
Total Current Liabilities 6.71M 15.29M 35.21M 8.15M
Total Liabilities 12.16M 21.17M 38.36M 27.54M
Common Stock 145.75M 97.32M 29.35M 28.89M
Retained Earnings -51.13M -42.74M -23.53M -17.59M
Treasury Stock 5.86M 3.91M 1.79M 702k
Other Stockholder Equity 5.86M 3.91M 1.79M 702k
Total Stockholder Equity 100.49M 58.49M 7.61M 12M
Net Tangible Assets 83.22M 40.41M -11.45M -8.08M

Aroa Biosurgery Limited (ASX:ARX) Balance Sheet Statement FAQ

1. How much Cash Aroa Biosurgery Limited has on their balance sheet?

As of 31 Mar 2022, Aroa Biosurgery Limited (ASX:ARX) has $6,165,000 of Cash.

2. What's the long term debt of Aroa Biosurgery Limited?

As per the latest Balance sheet of Aroa Biosurgery Limited (ASX:ARX), it has no Long term debt.

3. How much share holder equity does Aroa Biosurgery Limited has?

The Aroa Biosurgery Limited (ASX:ARX)'s balance sheet shows that it has $100,491,000 of Total stock holder equity.